Kirilys Therapeutics
Founders
BT Slingsby, MD, PhD, MPH - Co-Founder
Kapil Dhingra, MBBS - Co-Founder
Ashwin Ram, MD, MS - Chief Business Officer
Founded
2021
Stage
Seed
Invested
2022
Status
Private
Lightspeed Team
Dr. Galym Imanbayev - Partner
Dr. Shelley Chu - Partner
Jonathan MacQuitty - Partner

Kirilys Therapeutics, Inc. is a private, preclinical-stage biopharmaceutical company committed to the development of multiple precision oncology assets.Lightspeed team: Galym Imanbayev, Jonathan MacQuitty, Shelley Chu

Jonathan MacQuitty
Fraction Fraction

Faction Ventures, LLC (“Faction”) and Lightspeed Management Company, L.L.C. (“Lightspeed”) are separate businesses that operate independently of each other. Faction is a registered investment adviser under the United States Investment Advisers Act of 1940, as amended. Faction advises its own fund(s) and does not advise any Lightspeed clients, and Lightspeed does not advise Faction or any of its clients. Lightspeed and Faction are parties to an agreement pursuant to which Lightspeed holds certain interests in Faction and the fund(s) Faction manages.

continue to the Faction Site